PEG & ADCs
- Review: Hydrophilic linkers in Antibody-drug Conjugates
- Overview of ADC-Based Combination Therapies
- Antibody-Drug Conjugates With Dual Payloads Against Heterogeneous Tumors
- ADC Drugs For Non-small Cell Lung Cancer
- History and Development of Antibody Drug Conjugates (ADCs)
- The History Of ADC Drugs Development
- What Are ADC Payloads?
- FDA Approves Datroway (Datopotamab Deruxtecan) in HR+/HER2– Breast Cancer
- Development of Current Four Generation ADCs And Next Generation ADCs
- Three ADCs Expected To Be Approved In 2024-2025
